Lam K T, Lai S T, Kan Y S, Chan A Y
J Int Med Res. 1985;13(6):338-41. doi: 10.1177/030006058501300607.
The efficacy of sucralfate (1 g four times daily) and ranitidine (150 mg twice daily) in the short-term healing of duodenal ulcers has been assessed in a randomized single-blind trial involving 104 patients with three drop-outs. The healing rate at 3 weeks of 83% for sucralfate and 84% for ranitidine improved to 96% and 92%, respectively, at 6 weeks. The difference between the two treatment groups was not statistically significant. Smoking and male sex had no influence on the healing rates. Constipation was a prominent symptom in sucralfate treatment which was otherwise a safe and effective therapy.
在一项涉及104例患者且有3例退出的随机单盲试验中,评估了硫糖铝(每日4次,每次1克)和雷尼替丁(每日2次,每次150毫克)对十二指肠溃疡短期愈合的疗效。硫糖铝组3周时的愈合率为83%,雷尼替丁组为84%,6周时分别提高到96%和92%。两个治疗组之间的差异无统计学意义。吸烟和男性性别对愈合率无影响。便秘是硫糖铝治疗中的一个突出症状,不过该疗法总体安全有效。